Remus Pharmaceuticals Limited (NSE:REMUS)

India flag India · Delayed Price · Currency is INR
699.80
+41.80 (6.35%)
Apr 29, 2026, 3:29 PM IST
-30.89%
Market Cap 7.67B
Revenue (ttm) 7.48B
Net Income (ttm) 335.10M
Shares Out 11.66M
EPS (ttm) 27.37
PE Ratio 24.04
Forward PE n/a
Dividend 1.00 (0.15%)
Ex-Dividend Date Nov 14, 2025
Volume 17,000
Average Volume 5,465
Open 658.00
Previous Close 658.00
Day's Range 658.00 - 710.00
52-Week Range 580.00 - 1,139.50
Beta 0.22
RSI 63.04
Earnings Date May 15, 2026

About Remus Pharmaceuticals

Remus Pharmaceuticals Limited engages in the marketing, trading, and distribution of pharmaceuticals products and allied products in India and internationally. It is involved in trading of active pharmaceutical ingredient, as well as provides technical and consultancy services to various distributors and contract manufacturing services. The company offers tablet, hard and soft gelatine capsules, liquid and lyophilized injections, as well as pre-filled syringe, infusions, inhalers, nebulizers, nasal sprays and solutions, eye drops, creams, gels,... [Read more]

Industry Medical - Pharmaceuticals
Sector Healthcare
Founded 2015
Employees 68
Stock Exchange National Stock Exchange of India
Ticker Symbol REMUS
Full Company Profile

Financial Performance

In fiscal year 2025, Remus Pharmaceuticals's revenue was 6.20 billion, an increase of 191.33% compared to the previous year's 2.13 billion. Earnings were 290.70 million, an increase of 41.67%.

Financial Statements

News

There is no news available yet.